Reiko Kiwamoto

Physiologically based kinetic modeling of the bioactivation of myristicin

Amer J. Al-Malahmeh, Abdelmajeed Al-Ajlouni, Sebastiaan Wesseling et al. · Archives of Toxicology · 2016 · 41 citations · Full text

Pharmacy, Pharmacology, Toxicology +12

Mode of action based risk assessment of the botanical food-borne alkenylbenzene apiol from parsley using physiologically based kinetic (PBK) modelling and read-across from safrole

Abdalmajeed M. Alajlouni, Amer J. Al Malahmeh, Reiko Kiwamoto et al. · Food and Chemical Toxicology · 2016 · 33 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in human including interindividual variation indicates efficient detoxification and a negligible genotoxicity risk

Reiko Kiwamoto, A. Spenkelink, Ivonne M.C.M. Rietjens et al. · Archives of Toxicology · 2013 · 19 citations

Pharmacy, Pharmacology, Toxicology +16

Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations

Ala’ Ali Ahmad Al-Subeihi, Wasma Alhusainy, Reiko Kiwamoto et al. · Toxicology and Applied Pharmacology · 2014 · 16 citations

Natural Sciences, Biochemistry, Pharmacology +11

Next generation risk assessment for occupational chemical safety – A real world example with sodium-2-hydroxyethane sulfonate

Adam Wood, C. Breffa, Caroline Chaine et al. · Toxicology · 2024 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Toxicology +15